drugset / Trial / NCT01360151

Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy

NCT01360151

Unknown 16 enrolled Seoul St. Mary's Hospital
RandomizedParallel-groupOpen-labelDiagnostic

Summary

This is a prospective, comparative control analysis. The investigators want to evaluate the aqueous humor levels of vascular endothelial growth factor in polypoidal choroidal vasculopathy and the effect of photodynamic therapy and combination treatment of photodynamic therapy and Lucentis (Ranibizumab)on the level of vascular endothelial growth factor.

Timeline

Start
2011-02
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ranibizumab Monoclonal antibody 0.5 mg Intravitreal
Subject Verteporfin Other / unclassified 6 mg/m2 Intravenous
Subject Verteporfin Other / unclassified 15 mg Intravenous